Serum total and high-density lipoprotein phospholipids: Independent predictive value for cardiometabolic risk

Abstract

Objective: Given that serum phospholipids (PL) may serve as inflammation mediators, we studied whether they predicted metabolic syndrome (MetS), type-2 diabetes or coronary heart disease (CHD) risk in people prone to enhanced low-grade inflammation.